A new vaccine designed to protect young children in sub-Saharan Africa from infection from thePlasmodium falciparum parasite has been given a positive opinion by the European Medicines Agency even as its effectiveness was described as modest. ---Subscribe to MedNous to access this article--- Regulation & Policy Company News
